This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer: We're in the Grips of a Struggle

NEW YORK ( Real Money) -- These high-multiple stocks have your number, or at least the short sellers of them do.

We are in the grips of a titanic struggle where companies that are inventing incredibly important drugs go down almost every day. But it is as if we have no idea how to value them. No dividends, no buybacks, no earnings. That would be fine if we had some bellwether companies in the industry that we trusted or some takeovers that would define the bounds. But the two leaders, Celgene (CELG - Get Report) and Gilead (GILD - Get Report) both have flies right now, a generic challenge to Revlimid and a Big Pharma/Merck (MRK - Get Report) challenge to the Hep C pill respectively, so there's no backbone to the group.

In fact, these stocks are just paper tigers. You blow on them, they fall over. The opportunity to own them for a quick four points isn't worth the eight-point decline.

Same with software as a service. Nothing's changed. We aren't where they can hold yet. We aren't where they don't attract sellers that are obviously exacerbated by ETF/HFT action. 

Must Read: Jim Cramer: Where Faux Wisdom Makes Real Money

Plus, the opportunities away from these stocks are so spectacular that you don't need to focus on them. But I think that there is a predilection to do so in part because you don't want to leave the horse that got you here, but also because you simply aren't going to make up the performance you need to close the gap with the S&P with Ventas (VTR - Get Report) and Vornado (VNO - Get Report) or Duke (DUK - Get Report) and Dominion (D - Get Report). They can't generate the alpha you need, and I hate using the Greek terms.

As the long weekend beckons, maybe we can get some perspective about stocks that were loved when they were 100% higher than now that now seem worthless in the market's eyes.

But always remember, the year is long and the winning stocks don't have to win tomorrow to make up for the losses.

Random musings: Have a great holiday!

At the time of publication, Action Alerts PLUS, which Cramer co-manages as a charitable trust, was long CELG.

Editor's Note: This article was originally published at 7:14 a.m. EDT on Real Money on April 17.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs